Test ID: DABZO
Drug of Abuse, Benzodiazepine Screen with GC-MS Confirmation, Urine
Secondary ID 
A test code used for billing and in test definitions created prior to November 2011
505337
NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.
Yes
Useful For Suggests clinical disorders or settings where the test may be helpful
Confirmation of drug abuse involving benzodiazepines such as alprazolam, chlordiazepoxide, diazepam, flurazepam, lorazepam, and triazolam.
Reflex Tests Lists test(s) that may or may not be performed, at an additional charge, depending on the result and interpretation of the initial test(s)
| Test ID | Reporting Name | Available Separately | Always Performed |
|---|---|---|---|
| DAUBZ | Drug of Abuse, Benzo Conf, U | Yes | No |
Testing Algorithm Delineates situation(s) when tests are added to the initial order. This includes reflex and additional tests.
If the benzodiazepine screen is > or =200 ng/mL, then benzodiazepine confirmation is performed at an additional charge.
Method Name A short description of the method used to perform the test
DABZO/505337: Enzyme-Multiplied Immunoassay Technique (EMIT)
DAUBZ/500368: Gas Chromatography-Mass Spectrometry (GC-MS)
Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name
Drug of Abuse, Benzodiazepine, U
Aliases Lists additional common names for a test, as an aid in searching
Benzodiazepine DAU Screen, Urine
DAU Benzodiazepine Screen, Urine
Drugs of Abuse Benzodiazepine Screen, Urine
DAU Benzodiazepine Screen, Urine
Drugs of Abuse Benzodiazepine Screen, Urine
External
link
PDF
document
Excel
document
Word
document